Related references
Note: Only part of the references are listed.Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non-Small-Cell Lung Cancer Patients with EGFR Mutations
Rafael Rosell et al.
CLINICAL CANCER RESEARCH (2011)
Fast and accurate long-read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2010)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Rapid Detection of the Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer for Analysis of Acquired Resistance Using Molecular Beacons
Young-Hee Oh et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR
Marie Brevet et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissues
Sandrine Dufort et al.
ANALYTICAL BIOCHEMISTRY (2009)
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions
Martin L. Sos et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer.
Rafael Rosell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation
Hitoshi Miyazawa et al.
CANCER SCIENCE (2008)
Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer
Tomoya Fukui et al.
CLINICAL CANCER RESEARCH (2008)
The genome sequencer FLX™ system-longer reads, more applications, straight forward bioinformatics and more complete data sets
Marcus Droege et al.
JOURNAL OF BIOTECHNOLOGY (2008)
Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis
G. D. Smith et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells
Miguel A. Molina-Vila et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-akt-positive or never smoker patients with advanced non-small-cell lung cancer:: The ONCOBELL trial
Federico Cappuzzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?
H. Uramoto et al.
BRITISH JOURNAL OF CANCER (2007)
K-ras mutation detection in colorectal cancer using the Pyrosequencing technique
Angela Poehlmann et al.
PATHOLOGY RESEARCH AND PRACTICE (2007)
Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis
Kiyoaki Nomoto et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
Roman K. Thomas et al.
NATURE MEDICINE (2006)
Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay
H Asano et al.
CLINICAL CANCER RESEARCH (2006)
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp
Y Nagai et al.
CANCER RESEARCH (2005)
Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas
QL Pan et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Sensitive Sequencing method for KRAS mutation detection by pyrosequencing
S Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Erlotinib in lung cancer - Molecular and clinical predictors of outcome
MS Tsao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
W Pao et al.
PLOS MEDICINE (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
MC Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)